Miyanishi, Hajime
Kitazawa, Ayumu
Izuo, Naotaka
Muramatsu, Shin-ichi
Nitta, Atsumi http://orcid.org/0000-0001-6916-9160
Funding for this research was provided by:
Japan Society for the Promotion of Science (JP21H02632, 26293213)
Kobayashi International Scholarship Foundation
Smoking Research Foundation
Nagai Memorial Research Scholarship from the Pharmaceutical Society of Japa
Article History
Received: 10 January 2022
Revised: 2 March 2022
Accepted: 30 March 2022
First Online: 15 April 2022
Declarations
:
: SM has equity in Gene Therapy Research Institution, Co., Ltd., which commercializes the use of AAV vectors for gene therapy applications. To the extent that the work in this manuscript increases the value of these commercial holdings, SM has conflicts of interest. The other authors have no relevant financial or nonfinancial interests to disclose.
: All experimental procedures followed the National Institutes of Health Guidelines for the Care and Use of Laboratory Animals and they were approved by the Committee for Animal Experiments at the University of Toyama (2021PHA-16, 20).